GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 51 filers reported holding GEMINI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,994,000 | -2.9% | 2,435,125 | 0.0% | 3.07% | +6.8% |
Q2 2022 | $4,115,000 | +21.6% | 2,435,125 | 0.0% | 2.88% | +108.0% |
Q1 2022 | $3,385,000 | -52.2% | 2,435,125 | 0.0% | 1.38% | -20.6% |
Q4 2021 | $7,086,000 | -28.0% | 2,435,125 | 0.0% | 1.74% | -43.1% |
Q3 2021 | $9,838,000 | -37.6% | 2,435,125 | 0.0% | 3.06% | -50.7% |
Q2 2021 | $15,755,000 | -52.3% | 2,435,125 | 0.0% | 6.20% | -36.1% |
Q1 2021 | $32,996,000 | – | 2,435,125 | – | 9.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Opportunity Management V, LLC | 2,435,125 | $3,385,000 | 4.74% |
Foresite Capital Management V, LLC | 2,435,125 | $3,385,000 | 1.38% |
Atlas Venture Life Science Advisors, LLC | 5,254,365 | $7,304,000 | 0.92% |
Orbimed Advisors | 5,826,224 | $8,098,000 | 0.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,372,267 | $3,297,000 | 0.10% |
Boxer Capital, LLC | 1,300,000 | $1,807,000 | 0.09% |
Ikarian Capital, LLC | 443,096 | $615,000 | 0.08% |
HARVARD MANAGEMENT CO INC | 250,000 | $348,000 | 0.04% |
PURA VIDA INVESTMENTS, LLC | 496,120 | $690,000 | 0.02% |
Marquette Asset Management, LLC | 66,269 | $92,000 | 0.02% |